Royalties Drive up GeneNews' Q2 Revenues | GenomeWeb

NEW YORK (GenomeWeb News) – Canadian molecular diagnostics company GeneNews said after the close of the market Thursday that revenues for the second quarter increased nearly six-fold year over year.

The company posted C$56,304 (US$56,569) in revenues for the three months ended June 30, up from C$9,790 a year ago. GeneNews recorded C$51,833 in royalty payments, compared to zero a year ago, while sales were down to C$4,471 from C$9,790.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.